Michel Nussenzweig
Corporate Officer/Principal at Tri-Institutional Therapeutics Discovery Institute, Inc.
Network origin in Michel Nussenzweig first degree
Entity | Entity type | Industry | |
---|---|---|---|
Tri-Institutional Therapeutics Discovery Institute, Inc.
Tri-Institutional Therapeutics Discovery Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Memorial Sloan Kettering Cancer Center, Tri-Institutional Therapeutics Discovery Institute, Inc. is an American New York-based company that encourages the Tri-Institutional community to advance their biological discoveries to preclinical studies. The company provides technical support for academic projects and offers a menu of services to translate research discoveries from bench to bedside. Tri-Institutional Therapeutics Discovery Institute achieves its mission by leveraging the infrastructure, staff, and intellectual capital of its academic and industry partners, as well as the generous support of philanthropists. The company was founded by David A. Scheinberg.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michel Nussenzweig via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Private Equity Investor | |
DYAX CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERSANA THERAPEUTICS, INC. | Biotechnology | Consultant / Advisor | |
Annovation BioPharma, Inc.
Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Arteaus Therapeutics LLC
Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree | |
Global Positioning System
Global Positioning System Telecommunications EquipmentElectronic Technology Global Positioning System (GPS) is a government-operated satellite-based navigation system that provides location and time information. The private company is based in Woburn, MA. The GPS modernization program has added new civil signals to the system, including the L2C and L5 signals. The ground control and space segments of the GPS are also described on the gps.gov website. The website provides information about GPS accuracy and potential interference from other communication networks. Additionally, the website offers public information in Arabic and Mandarin Chinese about the GPS. The National Aeronautics and Space Administration (NASA) also holds meetings of the National Space-Based Positioning, Navigation and Timing (PNT) Advisory Board to discuss GPS-related topics. | Telecommunications Equipment | Corporate Officer/Principal | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
Princeton University | College/University | Doctorate Degree | |
Seton Hall University | College/University | Undergraduate Degree | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Founder Consultant / Advisor | |
Stanford Health Care
Stanford Health Care Hospital/Nursing ManagementHealth Services Stanford Health Care provides healthcare services. It services includes cardiac care, cancer treatment, neurosciences, surgery and organ transplants. The company was founded in 1956 and is headquartered in Stanford, CA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Lauri Strauss Leukemia Foundation | Corporate Officer/Principal | ||
EPIZYME, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
CONTRAFECT CORPORATION | Biotechnology | Director/Board Member | |
Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Harvard Medical School | College/University | Doctorate Degree | |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
Gerstner Sloan Kettering Graduate School of Biomedical Science | College/University | Corporate Officer/Principal | |
SURFACE ONCOLOGY, INC. | Biotechnology | Chief Executive Officer | |
Acera School | Founder | ||
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Sapience Therapeutics, Inc.
Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | Biotechnology | Director/Board Member | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Delinea, Inc. (United States)
Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ. | Biotechnology | Director/Board Member | |
SELLAS LIFE SCIENCES GROUP, INC. | Pharmaceuticals: Major | Director/Board Member | |
One Brave Idea, Inc.
One Brave Idea, Inc. Miscellaneous Commercial ServicesCommercial Services One Brave Idea, Inc. operates a science innovation center. The private company is based in New York. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Founder | |
BMS GmbH Beschickungssysteme Maschinen für Keramik und Umwelt
BMS GmbH Beschickungssysteme Maschinen für Keramik und Umwelt Industrial MachineryProducer Manufacturing BMS GmbH Beschickungssysteme Maschinen für Keramik und Umwelt is a German company that manufactures special purpose machinery. The private company is based in Goerlitz, Germany and was founded in 1994. | Industrial Machinery | Private Equity Investor | |
Centre of Nanotechnology | Founder | ||
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
AEROVATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Soilos, Inc.
Soilos, Inc. Regional BanksFinance Soilos, Inc. is a digital asset platform that provides a comprehensive crypto-as-a-service offering to leading banks, fintech institutions, and investment applications. The company is based in Valletta, MT, and has subsidiaries in the United States. The Maltese company simplifies the complex landscape of digital assets for its institutional clients with seamless price discovery and trade execution strategies at zero slippage and no hidden fees. Soilos is the largest, most reliable prime brokerage for the world's leading institutions and the first CFTC registered swap dealer. The company was founded by Raghuveer Yarlagadda and Prabhakar Reddy, and the CEO is Raghu Yarlagadda. | Regional Banks | Consultant / Advisor | |
Commonwealth Cancer Consortium, Inc. | Director/Board Member | ||
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Consultant / Advisor | |
Sloan-Kettering Institute for Cancer Research | Corporate Officer/Principal | ||
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
United States | 46 |
United Kingdom | 2 |
Germany | 2 |
India | 2 |
Bermuda | 2 |
Sectoral
Health Technology | 28 |
Consumer Services | 9 |
Finance | 4 |
Health Services | 3 |
Commercial Services | 3 |
Operational
Director/Board Member | 18 |
Corporate Officer/Principal | 16 |
Founder | 12 |
Consultant / Advisor | 7 |
Independent Dir/Board Member | 6 |
Most connected contacts
Insiders | |
---|---|
Dave Grayzel | 23 |
David Scheinberg | 17 |
Robert Copeland | 15 |
James Fagin | 1 |
- Stock Market
- Insiders
- Michel Nussenzweig
- Company connections